Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06CXL
|
|||
| Drug Name |
Anakinra
|
|||
| Synonyms |
Antril
Click to Show/Hide
|
|||
| Drug Type |
Protein/peptide drug
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20; ICD-9: 729] | Approved | [1] | |
| Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 3 | [2] | ||
| Therapeutic Class |
Antiviral Agents
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | HUMAN interleukin-1 receptor 1 (IL1R1) | Target Info | Antagonist | [3] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (BLA) 103950. | |||
| REF 2 | ClinicalTrials.gov (NCT04364009) Anakinra for COVID-19 Respiratory Symptoms. U.S. National Institutes of Health. | |||
| REF 3 | FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (BLA) 125166. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.